Welcome to our dedicated page for US Physical Therapy news (Ticker: $USPH), a resource for investors and traders seeking the latest updates and insights on US Physical Therapy stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect US Physical Therapy's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of US Physical Therapy's position in the market.
U.S. Physical Therapy, Inc. reported first-quarter 2024 results, highlighting a decrease in Adjusted EBITDA due to Medicare rate reductions and adverse weather. Despite this, net income increased, total revenue from physical therapy operations grew, and the company added new clinics. Industrial injury prevention services revenue also increased. Management raised full-year 2024 guidance to $82.5 million to $87.5 million. The company declared a dividend of $0.44 per share.
U.S. Physical Therapy, Inc. (
